Category: Hill-Rom Holdings Inc.
Hill-Rom closes the $250 million acquisition of Trumpf Medical and its line of operating room infrastructure products.
JenaValve taps ex-AtriCure chief David Drachman to be its new CEO.
, Bioject Medical Technologies Inc.
, Echo Therapeutics Inc.
, Hill-Rom Holdings Inc.
, Integrity Applications
, U.S. Veterans Affairs Dept. (VA)
, GI Dynamics
A federal appeals court overturns Stryker's win over Hill-Rom in a patent spat over hospital bed monitoring systems.
This week is all about Medtronic's blockbuster acquisition of Covidien for nearly $43 billion and the deal's wider implications for medtech; plus, Hill-Rom makes a move in Germany.
Hill-Rom says it's agreed to pay $250 million in cash for German operating room infrastructure maker Trumpf Medical.
Hill-Rom Holdings (NYSE:HRC) said today that it agreed to put up $250 million in cash for the operating room infrastructure arm of Germany's Trumpf Group.
Indiana-based Hill-Rom announces restructuring plans that will cut about 350 workers in hopes of saving $30 million per year as the company lowers its guidance for 2014.
Hill-Rom Holdings (NYSE:HRC) announced today that it will cut about 350 employees in efforts to save about $30 million annually as the device maker looks forward to a potentially tough year.
Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.